These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7811250)

  • 1. Rapid grouping of HIV-1 infection in subtypes A to E by V3 peptide serotyping and its relation to sequence analysis.
    Sherefa K; Sönnerborg A; Steinbergs J; Sällberg M
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1658-64. PubMed ID: 7811250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of no change in V3 loop antibody recognition pattern in HIV type 1-infected Ethiopians between 1988 and 1993.
    Sherefa K; Sällberg M; Sönnerborg A
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1551-6. PubMed ID: 7534097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia and Lithuania.
    Lukashov VV; Cornelissen MT; Goudsmit J; Papuashvilli MN; Rytik PG; Khaitov RM; Karamov EV; de Wolf F
    AIDS; 1995 May; 9(5):435-9. PubMed ID: 7639968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High specificity of V3 serotyping among human immunodeficiency virus type-1 subtype C infected patients with varying disease status and viral phenotype.
    Walker PR; Cilliers T; Choge IA; Taylor N; Cohen SS; Morris L
    J Med Virol; 2006 Oct; 78(10):1262-8. PubMed ID: 16927278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of discordance between sequencing and serological subtyping in a predominantly non-B subtype HIV-1 infected cohort.
    Smith M; Geretti AM; Osner N; Easterbrook P; Zuckerman M
    J Clin Virol; 2005 Aug; 33(4):312-8. PubMed ID: 16036181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotyping of HIV type 1 infections: definition, relationship to viral genetic subtypes, and assay evaluation. UNAIDS Network for HIV-1 Isolation and Characterization.
    Cheingsong-Popov R; Osmanov S; Pau CP; Schochetman G; Barin F; Holmes H; Francis G; Ruppach H; Dietrich U; Lister S; Weber J
    AIDS Res Hum Retroviruses; 1998 Mar; 14(4):311-8. PubMed ID: 9519892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1.
    Smith JD; Bruce CB; Featherstone AS; Downing RG; Biryahawaho B; Clegg JC; Carswell JW; Oram JD
    AIDS Res Hum Retroviruses; 1994 May; 10(5):577-83. PubMed ID: 7522494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotyping and genotyping of HIV-1 infection in residents of Khayelitsha, Cape Town, South Africa.
    Jacobs GB; de Beer C; Fincham JE; Adams V; Dhansay MA; van Rensburg EJ; Engelbrecht S
    J Med Virol; 2006 Dec; 78(12):1529-36. PubMed ID: 17063507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of HIV-1 subtypes: implications for vaccine formulations.
    Smith TL; van Rensburg EJ; Engelbrecht S
    J Med Virol; 1998 Nov; 56(3):264-8. PubMed ID: 9783696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of human immunodeficiency virus type 2 (hiv-2) infecting patients living in france.
    Damond F; Apetrei C; Robertson DL; Souquière S; Leprêtre A; Matheron S; Plantier JC; Brun-Vézinet F; Simon F
    Virology; 2001 Feb; 280(1):19-30. PubMed ID: 11162815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological approaches to subtyping of HIV-1 in injecting drug users in Russia: evidence of subtype homogeneity at the main sites of the epidemic.
    Bobkova MR; Kazennova EV; Selimova LM; Buravtsova EV; Lister S; Prilipov AG; Weber JN; Pokrovsky VV; Bobkov AF
    Int J STD AIDS; 2001 Jan; 12(1):34-40. PubMed ID: 11177480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence and diversity of different HIV-1 subtypes in South Africa, 2000-2001.
    Jacobs GB; Loxton AG; Laten A; Robson B; van Rensburg EJ; Engelbrecht S
    J Med Virol; 2009 Nov; 81(11):1852-9. PubMed ID: 19774685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of the HIV-1 variability in adults from Bucharest, 1992-1998.
    Chiţu V; Diaconu CC; Veliceasa D; Ruţă S; Grancea C; Târdei G; Cernescu CE
    Rom J Virol; 1999; 50(1-4):43-51. PubMed ID: 11601379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV type 1 V3 serotyping of Tanzanian samples: probable reasons for mismatching with genetic subtyping.
    Hoelscher M; Hanker S; Barin F; Cheingsong-Popov R; Dietrich U; Jordan-Harder B; Olaleye D; Nägele E; Markuzzi A; Mwakagile D; Minja F; Weber J; Gürtler L; Von Sonnenburg F
    AIDS Res Hum Retroviruses; 1998 Jan; 14(2):139-49. PubMed ID: 9462924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary infections with HIV-1 of women and their offspring in Rwanda: findings of heterogeneity at seroconversion, coinfection, and recombinants of HIV-1 subtypes A and C.
    Kampinga GA; Simonon A; Van de Perre P; Karita E; Msellati P; Goudsmit J
    Virology; 1997 Jan; 227(1):63-76. PubMed ID: 9007059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. V3 serological subtyping of human immunodeficiency virus type 2 infection is not relevant.
    Plantier JC; Damond F; Souquières S; Brun-Vézinet F; Simon F; Barin F
    J Clin Microbiol; 2001 Oct; 39(10):3803-7. PubMed ID: 11574625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of correlation between V3-loop peptide enzyme immunoassay serologic subtyping and genetic sequencing.
    Nkengasong JN; Willems B; Janssens W; Cheingsong-Popov R; Heyndrickx L; Barin F; Ondoa P; Fransen K; Goudsmit J; van der Groen G
    AIDS; 1998 Aug; 12(12):1405-12. PubMed ID: 9727560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of HIV-1 V3 serotyping in studying the HIV-1 epidemic in South Africa.
    Cheingsong-Popov R; Williamson C; Lister S; Morris L; van Harmelen J; Bredell H; Wood R; Sonnenberg P; van der Ryst E; Martin D; Weber J
    AIDS; 1998 May; 12(8):949-50. PubMed ID: 9631149
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of diagnostic efficiency of the recombinant protein modeling immunodominant epitope V3 of envelope gp120 for immunoenzyme detection for HIV-1 infection antibodies].
    Riabinina SA; Baranova EN; Sharipova IN; Susekina MI; Puzyrev VF; Obriadina AP; Burkov AN; Ulanova TI
    Mol Gen Mikrobiol Virusol; 2007; (3):33-6. PubMed ID: 17886471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodies.
    Polonis VR; De Souza MS; Chanbancherd P; Chantakulkij S; Jugsudee A; Loomis-Price LD; Vancott TC; Garner R; Markowitz LE; Brown AE; Birx DL
    AIDS Res Hum Retroviruses; 2001 Jan; 17(1):69-79. PubMed ID: 11177385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.